These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 30840849)
1. The combination of UCN-01 and ATRA triggers differentiation in ATRA resistant acute promyelocytic leukemia cell lines via RAF-1 independent activation of MEK/ERK. Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Cai X Food Chem Toxicol; 2019 Apr; 126():303-312. PubMed ID: 30840849 [TBL] [Abstract][Full Text] [Related]
2. Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK. Ding M; Weng XQ; Sheng Y; Wu J; Liang C; Cai X Food Chem Toxicol; 2018 Sep; 119():464-478. PubMed ID: 29097117 [TBL] [Abstract][Full Text] [Related]
3. RAF-1/MEK/ERK pathway regulates ATRA-induced differentiation in acute promyelocytic leukemia cells through C/EBPβ, C/EBPε and PU.1. Weng XQ; Sheng Y; Ge DZ; Wu J; Shi L; Cai X Leuk Res; 2016 Jun; 45():68-74. PubMed ID: 27101150 [TBL] [Abstract][Full Text] [Related]
4. Combined staurosporine and retinoic acid induces differentiation in retinoic acid resistant acute promyelocytic leukemia cell lines. Ge DZ; Sheng Y; Cai X Sci Rep; 2014 Apr; 4():4821. PubMed ID: 24769642 [TBL] [Abstract][Full Text] [Related]
5. Staurosporine enhances ATRA-induced granulocytic differentiation in human leukemia U937 cells via the MEK/ERK signaling pathway. Shi L; Weng XQ; Sheng Y; Wu J; Ding M; Cai X Oncol Rep; 2016 Nov; 36(5):3072-3080. PubMed ID: 27665842 [TBL] [Abstract][Full Text] [Related]
6. GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation. Jensen HA; Bunaciu RP; Varner JD; Yen A Cell Signal; 2015 Aug; 27(8):1666-75. PubMed ID: 25817574 [TBL] [Abstract][Full Text] [Related]
7. Combination of enzastaurin and ATRA exerts dose-dependent dual effects on ATRA-resistant acute promyelocytic leukemia cells. Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Li ZY; Cai X Am J Cancer Res; 2019; 9(5):906-926. PubMed ID: 31218101 [TBL] [Abstract][Full Text] [Related]
8. Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3. Lu H; Weng XQ; Sheng Y; Wu J; Xi HM; Cai X BMC Cancer; 2022 Jul; 22(1):749. PubMed ID: 35810308 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways. Hahn M; Li W; Yu C; Rahmani M; Dent P; Grant S Mol Cancer Ther; 2005 Mar; 4(3):457-70. PubMed ID: 15767555 [TBL] [Abstract][Full Text] [Related]
10. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells. Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153 [TBL] [Abstract][Full Text] [Related]
11. Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK/ERK signaling pathway. Huai L; Wang C; Zhang C; Li Q; Chen Y; Jia Y; Li Y; Xing H; Tian Z; Rao Q; Wang M; Wang J Biochem Biophys Res Commun; 2012 Jun; 422(3):398-404. PubMed ID: 22575507 [TBL] [Abstract][Full Text] [Related]
12. Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathways. Jia W; Yu C; Rahmani M; Krystal G; Sausville EA; Dent P; Grant S Blood; 2003 Sep; 102(5):1824-32. PubMed ID: 12738674 [TBL] [Abstract][Full Text] [Related]
13. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843 [TBL] [Abstract][Full Text] [Related]
14. Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation. Rashid A; Wang R; Zhang L; Yue J; Yang M; Yen A Exp Cell Res; 2020 Sep; 394(1):111989. PubMed ID: 32283065 [TBL] [Abstract][Full Text] [Related]
15. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor. Rashid A; Duan X; Gao F; Yang M; Yen A Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659 [TBL] [Abstract][Full Text] [Related]
16. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide. Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of differentiation induction and upregulation of CCAAT/enhancer-binding proteins and PU.1 in NB4 cells treated with combination of ATRA and valproic acid. Iriyama N; Yuan B; Yoshino Y; Hatta Y; Horikoshi A; Aizawa S; Takei M; Takeuchi J; Takagi N; Toyoda H Int J Oncol; 2014 Mar; 44(3):865-73. PubMed ID: 24379003 [TBL] [Abstract][Full Text] [Related]
18. Combination of Ethacrynic Acid and ATRA Triggers Differentiation and/or Apoptosis of Acute Myeloid Leukemia Cells through ROS. Li L; Xi HM; Lu H; Cai X Anticancer Agents Med Chem; 2024; 24(6):412-422. PubMed ID: 38204257 [TBL] [Abstract][Full Text] [Related]
19. NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK. Xiao C; Zhong L; Shan Z; Xu T; Gan L; Song H; Yang R; Li L; Liu B Int J Med Sci; 2016; 13(8):611-9. PubMed ID: 27499693 [TBL] [Abstract][Full Text] [Related]
20. Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells. Congleton J; MacDonald R; Yen A Leukemia; 2012 Jun; 26(6):1180-8. PubMed ID: 22182854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]